Full metadata record

DC FieldValueLanguage
dc.contributor.author이준아-
dc.contributor.author노은주-
dc.contributor.author오창현-
dc.contributor.author이소하-
dc.contributor.author심태보-
dc.contributor.author김종승-
dc.contributor.author유경호-
dc.date.accessioned2015-12-03T02:04:56Z-
dc.date.available2015-12-03T02:04:56Z-
dc.date.issued201508-
dc.identifier.citationVOL 30, NO 4, 607-614-
dc.identifier.issn14756366-
dc.identifier.other44718-
dc.identifier.urihttp://pubs.kist.re.kr/handle/201004/50104-
dc.description.abstractSynthesis of a new series of quinolinylaminopyrimidines 1a–k and quinazolinylmethylaminopyrimidines 2a–i containing aminoquinoline and aminoquinazoline as hinge regions is described. Their in vitro antiproliferative activities against A375P human melanoma cell line were tested. Among them, compounds 1h and 1k exhibited the highest antiproliferative activities against A375P cell line with IC50 values in sub-micromolar scale. Compounds 1i, 2b and 2g showed similar potency against A375P to Sorafenib as a reference compound. The representative compound 1h showed high, dose-dependent inhibition of MEK and ERK kinases.-
dc.publisherJournal of enzyme inhibition and medicinal chemistry-
dc.subjectMelanoma cell line-
dc.subjectQuinazoline-
dc.subjectQuinoline-
dc.subjectAntiproliferative-
dc.subjectMEK/ERK kinase inhibition-
dc.titleSynthesis of Quinolinylaminopyrimidines and Quinazolinylmethylaminopyrimidines with Antiproliferative Activity against Melanoma Cell Line-
dc.typeArticle-
Appears in Collections:
KIST Publication > Article
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE